Postmortem serum erythropoietin level as a marker of survival time in injury deaths

Forensic Science International

Volumn 200, Issue 1-3, 2010, Pages 117-122

  Quan, L ^a,b   Zhu, B L ^c   Ishikawa, T ^a   Michiue, T ^a   Zhao, D ^a   Ogawa, M ^d   Maeda, H ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SUN YAT SEN UNIVERSITY   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

^d OSAKA OHTANI UNIVERSITY   (Japan)

Author keywords

Erythropoietin; Forensic pathophysiology; Hemorrhage; Injury; Postmortem blood biochemistry; Survival time

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ERYTHROPOIETIN;

ABDOMINAL INJURY; ADULT; AGED; AORTA INJURY; ARTERY INJURY; ARTICLE; AUTOPSY; BLEEDING; BLUNT TRAUMA; CAROTID ARTERY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; ERYTHROPOIETIN BLOOD LEVEL; FEMALE; HEART INJURY; HUMAN; INFLAMMATION; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUBCLAVIAN ARTERY; SURVIVAL TIME; THORACIC AORTA; VISCERA;

EID: 77953911806     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2010.03.040     Document Type: Article

References (31)

1. Betz P., Nerlich A., Wilske J., Tübel J., Penning R., Eisenmenger W. The immunohistochemical localization of alpha 1-antichymotrypsin and fibronectin and its meaning for the determination of the vitality of human skin wounds. Int. J. Legal Med. 1993, 105:223-227.
2. Betz P. Histological and enzyme histochemical parameters for the age estimation of human skin wounds. Int. J. Legal Med. 1994, 107:60-68.
3. Betz P. Immunohistochemical parameters for the age estimation of human skin wounds. A review. Am. J. Forensic Med. Pathol. 1995, 16:203-209.
4. Kondo T., Ohshima T. The dynamics of inflammatory cytokines in the healing process of mouse skin wound: a preliminary study for possible wound age determination. Int. J. Legal Med. 1996, 108:231-236.
5. Kondo T., Ohshima T., Eisenmenger W. Immunohistochemical and morphometrical study on the temporal expression of interleukin-1alpha (IL-1alpha) in human skin wounds for forensic wound age determination. Int. J. Legal Med. 1999, 112:249-252.
6. Kondo T. Timing of skin wounds. Legal Med. 2007, 9:109-114.
7. Ogata M. Early diagnosis of diffuse brain damage resulting from a blunt head injury. Legal Med. 2007, 9:105-108.
8. Kagawa S., Matsuo A., Yagi Y., Ikematsu K., Tsuda R., Nakasono I. The time-course analysis of gene expression during wound healing in mouse skin. Legal Med. 2009, 11:70-75.
9. Ikematsu K., Tsuda R., Kondo T., Kondo H., Ozawa K., Ogawa S., Nakasono I. The expression of '150-kDa oxygen regulated protein (ORP-150)' in human brain and its relationship with duration time until death. Legal Med. 2004, 6:97-101.
10. Hausmann R., Betz P. The course of MIB-1 expression by cerebral macrophages following human brain injury. Legal Med. 2002, 4:79-83.
11. Quan L., Fujita M.Q., Zhu B.-L., Ishida K., Maeda H. Immunohistochemical distribution of C-reactive protein in the hepatic tissue in forensic autopsy. Forensic Sci. Int. 2000, 113:177-182.
12. Fujita M.Q., Zhu B.-L., Ishida K., Quan L., Oritani S., Maeda H. Serum C-reactive protein levels in postmortem blood-an analysis with special reference to the cause of death and survival time. Forensic Sci. Int. 2002, 130:160-166.
13. Ishikawa T., Hamel M., Zhu B.-L., Li D.R., Zhao D., Michiue T., Maeda H. Comparative evaluation of postmortem serum concentrations of neopterin and C-reactive protein. Forensic Sci. Int. 2008, 179:135-143.
14. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol. Rev. 1992, 72:449-489.
15. Bunn H.F., Poyton R.O. Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 1996, 76:839-885.
16. Eckardt K.U., Kurtz A. Regulation of erythropoietin production. Eur. J. Clin. Invest. 2005, 35:13-19.
17. Eckardt K.U., Boutellier U., Kurtz A., Schopen M., Koller E.A., Bauer C. Rate of erythropoietin formation in humans in response to acute hypobaric hypoxia. J. Appl. Physiol. 1989, 66:1785-1788.
18. Opasich C., Cazzola M., Scelsi L., De Feo S., Bosimini E., Lagioia R., Febo O., Ferrari R., Fucili A., Moratti R., Tramarin R., Tavazzi L. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur. Heart J. 2005, 26:2232-2237.
19. Koury M.J. Erythropoietin: the story of hypoxia and a finely regulated hematopoietic hormone. Exp. Hematol. 2005, 33:1263-1270.
20. Katavetin P., Inagi R., Miyata T., Shao J., Sassa R., Adler S., Eto N., Kato H., Fujita T., Nangaku M. Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem. Biophys. Res. Commun. 2007, 359:928-934.
21. Quan L., Zhu B.-L., Ishikawa T., Michiue T., Zhao D., Li D.R., Ogawa M., Maeda H. Postmortem serum erythropoietin levels in establishing the cause of death and survival time at medicolegal autopsy. Int. J. Legal Med. 2008, 122:481-487.
22. Masaki Y., Oka N., Furuya H., Ohguni S., Takagi C., Sato T., Notsu K., Kato Y. Clinical use of serum erythropoietin determination by Recombigen EPO RIA kit. Jpn. J. Nucl. Med. 1992, 29:701-707. (Japanese).
23. Kato Y., Takagi C., Tanaka J., Masaki Y., Furuya H. Effect of daily subcutaneous administration of recombinant erythropoietin on chronic anemia in rheumatoid arthritis. Int. Med. 1994, 33:193-197.
24. Flack C.P., Woollen J.W. Prevention of interference by dextran with biuret-type assay of serum proteins. Clin. Chem. 1984, 30:559-561.
25. Abdelrahman M., Sharples E.J., McDonald M.C., Collin M., Patel N.S., Yaqoob M.M., Thiemermann C. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 2004, 22:63-69.
26. Hobisch-Hagen P., Wiedermann F., Mayr A., Fries D., Jelkmann W., Fuchs D., Hasibeder W., Mutz N., Klingler A., Schobersberger W. Blunted erythropoietic response to anemia in multiply traumatized patients. Crit. Care Med. 2001, 29:743-747.
27. Carey L.C., Lowery B.D., Cloutier C.T. Hemorrhagic shock. Curr. Probl. Surg. January 1971, 3-48.
28. Ljunggvist U. Platelets in shock and trauma. J. Surg. Res. 1973, 15:132-162.
29. Erber W.N., Perry D.J. Plasma and plasma products in the treatment of massive haemorrhage. Best Pract. Res. Clin. Hematol. 2006, 19:97-112.
30. Childs E.W., Udobi K.F., Hunter F.A., Dhevan V. Evidence of transcellular albumin transport after hemorrhagic shock. Shock 2005, 23:565-570.
31. Sakai H., Takeoka S., Wettstein R., Tsai A.G., Intaglietta M., Tsuchida E. Systemic and microvascular responses to hemorrhagic shock and resuscitation with Hb vesicles. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H1191-1199.